Patrick Lamy, Senior VP, Commercial Strategy at Akero Therapeutics, Inc. (AKRO), sold 4,000 shares at $50.46 ($201K) on 2025-06-02, disclosed to the SEC on 2025-06-04.
Scheduled sale ($201k) by Senior VP, Commercial Strategy under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.40 | 600 | $30K | 14.7% |
| 2 | $50.46 | 3,300 | $167K | 82.7% |
| 3 | $51.04 | 100 | $5K | 2.5% |
| Total | $50.32 avg | 4,000 | $201K | 100% |
| Filing → |
| AKRO | SELL | 2025-06-20 | $108K | — | Filing → |
| AKRO | SELL | 2025-06-12 | $50K | — | Filing → |
| AKRO | SELL | 2025-05-23 | $200K | — | Filing → |